Q-line Biotech Limited

Q-Line Biotech Limited (QLINE) is a micro-cap Healthcare company valued at ₹1,401 crore operating in Medical Equipment & Supplies on the NSE and BSE.

Recent price move

Q-Line Biotech Limited last traded at ₹598, down 4.91% on the day.

Recent developments

On 2026-05-31, promoter holding remained at 67.51%. On 2026-05-31, the company reported a net profit of ₹34 crore for the latest quarter, up from ₹9 crore in the same quarter a year earlier. On 2026-05-31, the company did not pay out any dividend despite reporting repeated profits.

Financial performance

The company's business improved significantly, with annual net profit rising 100.0% to ₹56 crore, while annual revenue grew 8.9% to ₹342 crore. However, the latest quarter showed a drop in revenue of -8.8% compared to the same quarter a year earlier, despite a sharp increase in net profit of +277.8%.

Valuation multiples

The stock trades at 17.5 times earnings, a discount to the Healthcare median of 32.0, 3.42 times book value.

Things to watch

The stock is 14.4% below its 52-week high. The company is not paying out any dividend despite reporting repeated profits. The latest quarter revenue fell -8.8% compared to the same quarter a year earlier.

Where it stands

The company reported a net profit of ₹34 crore for the latest quarter, up from ₹9 crore in the same quarter a year earlier, while revenue fell -8.8%. The stock is 14.4% below its 52-week high. The company's net profit margin rose 7.5 percentage points to 16.4%.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.